Characteristics of vasospastic angina with exercised-induced ischemia--analysis of parameters of hemostasis and fibrinolysis
- PMID: 8803721
- DOI: 10.1253/jcj.60.277
Characteristics of vasospastic angina with exercised-induced ischemia--analysis of parameters of hemostasis and fibrinolysis
Abstract
To characterize the vasospastic angina patients with exercise-induced ischemia, we measured hemostasis (platelet factor 4; PF4, fibrinopeptide A; FPA) and fibrinolytic parameters (tissue plasminogen activator antigen; t-PA, free plasminogen activator inhibitor-1 antigen; free PAI-1) in 15 normal subjects and 33 vasospastic angina patients without significant coronary artery stenosis (less than 50% stenosis). All of the vasospastic angina patients began to feel chest pain within 3 months before diagnostic coronary angiography. Blood samples were obtained from all of the study patients at 8:30-9:30 am before exercise 201Tl emission computed tomography. Vasospastic angina patients were divided into 2 groups; 15 patients with exercise-induced ischemia (group 1) and 18 patients without exercise-induced ischemia (group 2). On coronary angiography, the severity of coronary artery stenosis at the site of spasm in group 1 (34 +/- 5%) was greater than that in group 2 (18 +/- 3%). Plasma FPA and PF 4 levels in group 1 were also significantly higher than those in normal subjects and group 2. Plasma t-PA and free PAI-1 levels in group 1 were significantly higher than those in normal subjects and group 2. Plasma levels of free PAI-1 group 2 were also significantly higher than those in normal subjects. The present study demonstrated that all of the patients with vasospastic angina had impaired fibrinolysis, and these patients with exercise-induced ischemia showed enhanced platelet activation, an enhanced coagulation system, and advanced atherosclerotic lesions. These results suggest that vasospastic angina with exercise-induced ischemia puts patients at increased risk for thrombus formation.
Similar articles
-
Circadian fluctuations of tissue plasminogen activator antigen and plasminogen activator inhibitor-1 antigens in vasospastic angina.Am Heart J. 1992 Oct;124(4):854-60. doi: 10.1016/0002-8703(92)90964-w. Am Heart J. 1992. PMID: 1529901
-
Assessment of quantitative exercise thallium-201 emission computed tomography in patients with vasospastic angina--value of washout rate analysis.Jpn Circ J. 1994 Jun;58(6):379-88. doi: 10.1253/jcj.58.379. Jpn Circ J. 1994. PMID: 8065009
-
Effects of beraprost sodium, a new prostaglandin I2 analog, on parameters of hemostasis, fibrinolysis, and myocardial ischemia in patients with exertional angina.Cardiovasc Drugs Ther. 1995 Aug;9(4):601-7. doi: 10.1007/BF00878093. Cardiovasc Drugs Ther. 1995. PMID: 8547211 Clinical Trial.
-
[Blood coagulation and fibrinolysis in ischemic heart disease].Rinsho Byori. 1994 Jan;42(1):39-44. Rinsho Byori. 1994. PMID: 8107282 Review. Japanese.
-
Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.Dan Med Bull. 1993 Sep;40(4):383-408. Dan Med Bull. 1993. PMID: 8222763 Review.
Cited by
-
Gender-specific prognosis and risk impact of C-reactive protein, hemoglobin and platelet in the development of coronary spasm.Int J Med Sci. 2013;10(3):255-64. doi: 10.7150/ijms.5383. Epub 2013 Jan 22. Int J Med Sci. 2013. PMID: 23372432 Free PMC article.
-
Left ventricular free wall rupture possibly induced by coronary spasm. Surgical repair in the emergency room.Jpn J Thorac Cardiovasc Surg. 2001 Jul;49(7):461-5. doi: 10.1007/BF02913914. Jpn J Thorac Cardiovasc Surg. 2001. PMID: 11517584
-
The Myocardial Bridge: Potential Influences on the Coronary Artery Vasculature.Clin Med Insights Cardiol. 2019 May 1;13:1179546819846493. doi: 10.1177/1179546819846493. eCollection 2019. Clin Med Insights Cardiol. 2019. PMID: 31068756 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous